Idera Pharmaceuticals, Inc.
(NASDAQ : IDRA)

( )
IDRA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.00%104.101.1%$1332.57m
GILDGilead Sciences, Inc.
0.00%72.440.9%$675.30m
AMGNAmgen Inc.
0.00%170.001.1%$499.55m
BIIBBiogen Inc.
1.02%317.161.2%$472.85m
REGNRegeneron Pharmaceuticals, Inc.
0.00%391.592.7%$363.74m
ALXNAlexion Pharmaceuticals, Inc.
0.00%110.871.9%$288.55m
VRTXVertex Pharmaceuticals Incorporated
0.00%147.411.9%$237.28m
INCYIncyte Corporation
0.00%105.472.5%$187.59m
ALNYAlnylam Pharmaceuticals, Inc
0.00%127.5110.6%$184.43m
ILMNIllumina, Inc.
0.00%209.023.5%$165.18m
NKTRNektar Therapeutics
0.00%44.996.1%$146.11m
JUNOJuno Therapeutics, Inc.
0.00%58.6413.5%$138.44m
BMRNBioMarin Pharmaceutical Inc.
0.00%82.884.4%$117.68m
SRPTSarepta Therapeutics, Inc.
0.00%56.1116.8%$117.17m
BLUEBluebird Bio, Inc.
0.00%163.2017.2%$116.94m

Company Profile

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel oligonucleotide therapeutics for oncology and rare diseases. The company uses two distinct proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor targeting technology and third-generation antisense technology. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.